Sandoz settlement with end payors in US drug litigation gets final approval
MLex Summary: Sandoz’s $275 million settlement with end payors received final approval from a US federal judge to resolve US price-fixing claims over generic pharmaceuticals.See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article